08Dec/09

US panel backs Novartis transplant drug — FDA – Reuters

US panel backs Novartis transplant drug — FDA
Reuters
VX) drug to prevent rejection of transplanted kidneys, a Food and Drug Administration spokeswoman said on Monday. The panel voted 11-1 to urge FDA clearance …
Panel Recommends Everolimus in Kidney TransplantMedPage Today
FDA Panel Recommends Agency OK Novartis Kidney DrugWall Street Journal
Advisory panel recommends everolimus tablets for approvalCardiology Today

all 12 news articles »